APA (7th ed.) Citation

Remawi, H. A., Lindén, M., Zhao, Z., Pandita, A., Rudin, A., Ny, L., . . . Levin, M. Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Remawi, Hifaa Al, Maria Lindén, Zhiyuan Zhao, Ankur Pandita, Anna Rudin, Lars Ny, Sara Bjursten, and Max Levin. Immune-related Hepatitis and Hypophysitis Are Associated with Superior Survival in Melanoma Patients Treated with Combined Ipilimumab and Nivolumab. Taylor & Francis Group.

MLA (9th ed.) Citation

Remawi, Hifaa Al, et al. Immune-related Hepatitis and Hypophysitis Are Associated with Superior Survival in Melanoma Patients Treated with Combined Ipilimumab and Nivolumab. Taylor & Francis Group.